Pa05g1347

Functional evidence

eggNOG

Preferred name: FPA | Seed ortholog: 337451.A0A443NY57 | COG: S | eggNOG OG: RRM_1@131221|Brp-26, RRM_1@131567|PG-17, RRM_1@2759|fR-20, SPOC@131567|A-1*, SPOC@2759|B-2!, SPOC@35493|v-7

Gene Ontology

GO:0000122 negative regulation of transcription by RNA polymerase II; GO:0000381 regulation of alternative mRNA splicing, via spliceosome; GO:0000398 mRNA splicing, via spliceosome; GO:0001510 RNA methylation; GO:0001569 branching involved in blood vessel morphogenesis; GO:0001889 liver development; GO:0003674 molecular_function; GO:0003682 chromatin binding; GO:0003697 single-stranded DNA binding; GO:0003700 DNA-binding transcription factor activity; GO:0003711 transcription elongation factor activity; GO:0003714 transcription corepressor activity; GO:0003723 RNA binding; GO:0003729 mRNA binding; GO:0005515 protein binding; GO:0005634 nucleus; GO:0006355 regulation of DNA-templated transcription; GO:0006396 RNA processing; GO:0006406 mRNA export from nucleus; GO:0007221 positive regulation of transcription of Notch receptor target; GO:0007283 spermatogenesis; GO:0007379 segment specification; GO:0007400 neuroblast fate determination; GO:0007403 glial cell fate determination; GO:0007411 axon guidance; GO:0007422 peripheral nervous system development; GO:0007548 sex differentiation; GO:0008150 biological_process; GO:0008270 zinc ion binding; GO:0008586 imaginal disc-derived wing vein morphogenesis; GO:0009048 dosage compensation by inactivation of X chromosome; GO:0010628 positive regulation of gene expression; GO:0030674 protein-macromolecule adaptor activity; GO:0031048 regulatory ncRNA-mediated heterochromatin formation; GO:0034244 negative regulation of transcription elongation by RNA polymerase II; GO:0035222 wing disc pattern formation; GO:0035321 maintenance of imaginal disc-derived wing hair orientation; GO:0038163 thrombopoietin-mediated signaling pathway; GO:0045638 negative regulation of myeloid cell differentiation; GO:0045652 regulation of megakaryocyte differentiation; GO:0045892 negative regulation of DNA-templated transcription; GO:0045893 positive regulation of DNA-templated transcription; GO:0048106 establishment of thoracic bristle planar orientation; GO:0048536 spleen development; GO:0048749 compound eye development; GO:0050769 positive regulation of neurogenesis; GO:0060047 heart contraction; GO:0060412 ventricular septum morphogenesis; GO:0060674 placenta blood vessel development; GO:0060816 random inactivation of X chromosome; GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding; GO:0090263 positive regulation of canonical Wnt signaling pathway; GO:0097190 apoptotic signaling pathway; GO:0140002 histone H3K4me3 reader activity; GO:0141006 transposable element silencing by piRNA-mediated heterochromatin formation; GO:0141196 transposable element silencing by piRNA-mediated DNA methylation; GO:2000737 negative regulation of stem cell differentiation

KEGG

EC: ec:4.6.1.1, ec:6.1.1.6 | KO: K04567, K11265, K13190, K17596, K18667, K25100 | Pathway: 00230, 00970, 01100, 04330 | BRITE: 00001, 01000, 01007, 01009, 01613, 03016, 03019, 03036, 03041